Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
British Journal of Clinical Pharmacology|December 1, 1980
The effect of beta-adrenoceptor agonists and antagonists on gastric emptying in manM R Rees, R A Clark, C D Holdsworth, et al.Gut|October 1, 1981
Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndromeC L Corbett, S Thomas, N W Read, et al.Gut|February 1, 1977
Relationship between changes in intraluminal pressure and transmural potential difference in the human and canine jejunum in vivoN W Read, R H Smallwood, R J Levin, et al.British Medical Journal|March 24, 1979
Upper gastrointestinal endoscopy: its effects on patient managementC D Holdsworth, K D Bardhan, G V Balmforth, et al.Gut|June 1, 1988
Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitisS S Rao, N W Read, J A Stobart, et al.Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitisJ C Mansfield, M H Giaffer, P A Cann, et al.Gut|May 1, 1989
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyS S Rao, S A Dundas, C D Holdsworth, et al.Gut|January 1, 1993
Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitisA B Hawthorne, C O Record, C D Holdsworth, et al.Gastroenterology|March 1, 1994
Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonistJ C Mansfield, H Holden, J K Tarlow, et al.Alimentary Pharmacology & Therapeutics|January 9, 1999
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator groupJ R Green, J A Gibson, G D Kerr, et al.Pageof 7